The Beneficial Effects of Microflora, Especially Obligate Anaerobes, and Their Products on the Colonic Environment in Inflammatory Bowel Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|8|1047-1053

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.8, 2005-03, pp. : 1047-1053

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

By Mitsuyama Keiichi   Sata Michio  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2095-2103

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By >   Pardi Darrell S.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite

Macrophages in Inflammatory Bowel Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and Inflammatory Bowel Disease

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 201-224

Bentham Science Publishers

Access to resources Recommend Favorite